Johnson & Johnson’s Covid vaccine to be imported in India

Must read

The baby care product company Johnson & Johnson’s is now allowed to start the vaccination process immediately. It has shown side effects like blood clotting in 15 people out of 8 million.

India is expected to import its single-shot coronavirus vaccine after ‘full & finish’ by the end of June or starting of July 2021.

Ms. Renu Swarup, the secretary of the Department of Biotechnology, Minister of Sciences and Technology, mentioned that “The Johnson & Johnson’s vaccines are expected to be imported to India by June-July 2021. Johnson & Johnson’s is working closely with Biological E to facilitate the ongoing tech transfer to India,” as per ANI reports.

She further added that Johnson & Johnson’s vaccine candidate “leverages the adenovirus vector-based delivery system.”

“To expand the manufacturing capacity in India, Johnson & Johnson has signed a tech-transfer agreement with Biological E Limited for the manufacturing of their investigational single dose, SARS-CoV-2 vaccine candidate, Ad26.COV2.S. This would add to the manufacturing capacity of India,” she said.

She also mentioned that Biological E is also working on its own candidate that has completed the trial.

“The estimated manufacturing capacity of Biological E, for this vaccine candidate, is about 600 billion doses per annum.”

More articles

- Advertisement -

Startup

Nykaa Inks Pact With Apparel Group To Fuel Middle-East Ops

Nykaa’s board gave its assent for the partnership with the UAE-based Apparel Group on October 6 The move will enable Nykaa to leverage Apparel...
- Advertisement -

Latest article